Piper Sandler Companies announced the addition of Christian Draisbach as a managing director to its healthcare investment banking team. Draisbach will be responsible for advising and supporting clients in the biopharma sector.
Draisbach brings 20 years of experience advising biopharma executives and boards on complex strategic initiatives, M&A, divestitures, and partnership transactions across the U.S., Europe, and Asia. He previously worked at Centerview Partners and Morgan Stanley.
His extensive transaction experience, spanning from early development-stage private deals to large public transactions, is expected to drive Piper Sandler's biopharma M&A business both domestically and internationally.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.